5,207 Shares in Relx Plc (NYSE:RELX) Acquired by Fiduciary Trust Co

Fiduciary Trust Co acquired a new stake in Relx Plc (NYSE:RELX) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund acquired 5,207 shares of the technology company’s stock, valued at approximately $237,000.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in RELX. Private Trust Co. NA boosted its stake in Relx by 19.2% during the 4th quarter. Private Trust Co. NA now owns 1,237 shares of the technology company’s stock worth $56,000 after purchasing an additional 199 shares during the period. Sage Mountain Advisors LLC boosted its stake in shares of Relx by 5.1% during the fourth quarter. Sage Mountain Advisors LLC now owns 5,292 shares of the technology company’s stock worth $240,000 after buying an additional 258 shares during the period. DRW Securities LLC grew its holdings in shares of Relx by 5.9% during the fourth quarter. DRW Securities LLC now owns 4,652 shares of the technology company’s stock worth $211,000 after buying an additional 259 shares during the last quarter. Kovitz Investment Group Partners LLC increased its position in Relx by 3.4% in the 4th quarter. Kovitz Investment Group Partners LLC now owns 8,159 shares of the technology company’s stock valued at $371,000 after acquiring an additional 267 shares during the period. Finally, Marks Group Wealth Management Inc increased its position in Relx by 1.3% in the 4th quarter. Marks Group Wealth Management Inc now owns 26,196 shares of the technology company’s stock valued at $1,190,000 after acquiring an additional 325 shares during the period. Hedge funds and other institutional investors own 15.02% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts have weighed in on RELX shares. The Goldman Sachs Group initiated coverage on Relx in a research note on Wednesday, March 26th. They issued a “buy” rating on the stock. Morgan Stanley reiterated an “overweight” rating on shares of Relx in a research report on Wednesday, April 16th. StockNews.com cut shares of Relx from a “buy” rating to a “hold” rating in a research note on Tuesday, March 4th. Finally, Barclays upgraded shares of Relx from an “equal weight” rating to an “overweight” rating in a research note on Friday, March 14th. One analyst has rated the stock with a hold rating, four have assigned a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat, Relx currently has an average rating of “Buy”.

Relx Stock Performance

Shares of RELX stock opened at $51.79 on Tuesday. The company has a current ratio of 0.52, a quick ratio of 0.47 and a debt-to-equity ratio of 1.46. The stock has a 50 day simple moving average of $50.66 and a 200-day simple moving average of $48.75. The company has a market cap of $95.86 billion, a price-to-earnings ratio of 27.85, a price-to-earnings-growth ratio of 2.73 and a beta of 0.86. Relx Plc has a 12-month low of $42.77 and a 12-month high of $55.21.

Relx Increases Dividend

The firm also recently disclosed a semi-annual dividend, which will be paid on Wednesday, June 25th. Shareholders of record on Friday, May 9th will be given a $0.5586 dividend. This is a boost from Relx’s previous semi-annual dividend of $0.23. The ex-dividend date of this dividend is Friday, May 9th. This represents a yield of 1.6%. Relx’s dividend payout ratio is presently 59.68%.

Relx Profile

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.